SCHEMBL23846375

SCHEMBL23846375

CCc1ccnc(C(=O)Nc2ccc(OC)c(S(=O)(=O)Nc3c(C)cccc3C)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
LMNA P02545 2/20 0.52
APOBEC3G Q9HC16 1/20 0.49
GRM4 Q14833 4/20 0.48
ALPL P05186 1/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 1/20 0.46
ALOX12 P18054 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
KDM4E B2RXH2 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
POLB P06746 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23846582 0.87 LMNA (0.56) MEN1KMT2ALMNAAPOBEC3GALPL
SCHEMBL23846422 0.82 MAPT (0.50) MEN1KMT2ALMNAAPOBEC3GGRM4
SCHEMBL23846407 0.81 MEN1 (0.51) MEN1KMT2ALMNAAPOBEC3GGRM4
SCHEMBL23846668 0.81 MEN1 (0.50) MEN1KMT2ALMNAAPOBEC3GGRM4
SCHEMBL25754596 0.81 MEN1 (0.52) MEN1KMT2ALMNAGRM4MAPT
SCHEMBL23846526 0.80 KMT2A (0.49) MEN1KMT2ALMNAGRM4ALPL
SCHEMBL25754563 0.79 LMNA (0.46) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL23833419 0.78 MAPT (0.53) MEN1KMT2ALMNAGRM4MAPT
SCHEMBL23846435 0.78 ALDH1A1 (0.63) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL25754548 0.78 MEN1 (0.53) MEN1KMT2ALMNAAPOBEC3GMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
WO-2021188880-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 MEN1 3902/4885KMT2A 4864/4885LMNA 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.